screen
test
extract
varieti
pharmacolog
target
order
benefit
immens
natur
chemic
divers
concern
mani
laboratori
worldwid
sever
success
record
find
new
activ
natur
product
becom
new
drug
new
sourc
inspir
drug
view
vast
amount
research
subject
surpris
drug
candid
found
view
fundament
reflect
upon
approach
drug
discoveri
program
technic
process
use
along
inher
difficulti
bias
base
extens
survey
recent
public
discuss
origin
varieti
natur
chemic
divers
well
strategi
potenti
embrac
divers
seem
us
difficulti
area
could
relat
technic
approach
use
present
review
begin
synthet
use
discoveri
strategi
exemplifi
key
point
order
address
limit
appear
one
challeng
natur
productbas
drug
discoveri
program
easier
access
renew
sourc
plantderiv
product
maxim
use
data
togeth
explor
chemic
divers
work
reason
suppli
natur
productbas
entiti
could
way
answer
challeng
suggest
altern
way
access
explor
part
chemic
divers
vitro
cultur
also
reinforc
import
organ
make
avail
worldwid
knowledg
inventori
natur
product
sourc
final
focus
strategi
base
synthet
biolog
synthes
allow
reach
industri
scale
suppli
approach
base
opportun
lie
untap
natur
plant
chemic
divers
also
consid
sever
review
like
updat
survey
newman
cragg
point
fact
mani
drug
market
natur
origin
author
state
new
chemic
entiti
approv
drug
pure
synthet
origin
remain
one
biolog
entiti
peptid
residu
includ
therapeut
antibodi
vaccin
littl
less
half
new
drug
exactli
natur
origin
deriv
inspir
natur
compound
furthermor
anticanc
area
approv
nonbiolog
compound
period
pure
synthet
ie
deriv
natur
compound
natur
compound
newman
cragg
natur
origin
differ
definit
author
account
three
categori
unalt
natur
pure
product
defin
mixtur
natur
product
np
natur
product
deriv
isol
plant
live
organ
fungi
spong
lichen
microorgan
product
modifi
medicin
chemistri
mani
exampl
anticanc
drug
docetaxel
paclitaxel
vinblastin
podophyllotoxin
etoposid
steroid
hormon
progesteron
norgestrel
cortison
cardiac
glycosid
digitoxigenin
antibiot
like
penicillin
streptomycin
cephalosporin
see
ia
ross
exampl
furthermor
rodrigu
et
al
point
fact
fragment
deriv
natur
structur
sourc
divers
molecul
new
drug
design
thank
fragmentbas
drug
discoveri
approach
erlanson
et
al
mortenson
et
al
bachmann
besid
understand
patholog
process
sourc
molecul
main
concern
pharmaceut
industri
vast
librari
compound
establish
order
feed
research
exampl
midsiz
pharmaceut
compani
common
find
librari
compound
big
pharma
number
sever
million
rang
macarron
et
al
knowledg
also
case
nation
chines
compound
librari
shanghai
china
http
encnclorgcn
final
nation
transnat
effort
report
creat
depositori
compound
use
screen
program
academi
see
horvath
et
al
europ
thornburg
et
al
nihnci
effort
addit
vendor
also
sell
librari
compound
compos
larg
divers
build
accord
differ
principl
boss
et
al
sever
public
deal
compound
chosen
langer
et
al
follow
lipinski
rule
lipinski
et
al
lipinski
virtual
glaab
real
systemat
test
target
organ
subclass
compound
design
potenti
interact
channel
receptor
enzym
etc
furthermor
composit
librari
relat
main
categori
moleculessmal
synthet
compound
druglik
organ
compound
peptid
protein
sugar
nucleosid
natur
compoundscan
greatli
vari
function
pharma
compani
cultur
say
compound
alreadi
synthes
given
compani
well
sensit
medicin
chemist
screen
peopl
decis
incorpor
natur
product
made
pure
welldefin
compound
extract
select
accord
differ
criteria
pharmacognosi
ethnopharmacolog
even
tradit
knowledg
tradit
exist
use
botan
medicin
plant
empir
knowledg
accumul
age
pass
gener
modern
pharmacolog
explor
valid
probabl
minor
part
knowledg
attempt
ration
use
plant
sourc
drug
first
possibl
approach
would
way
guid
drug
discoveri
project
anoth
total
differ
approach
base
use
highthroughput
screen
ht
emerg
one
two
decad
ago
aim
explor
systemat
immens
chemic
divers
secondari
metabolit
base
technolog
develop
discoveri
tool
miniatur
autom
atanasov
et
al
sens
increas
amount
compound
test
simultan
scientif
ration
select
compound
thank
grow
capac
chemoinformat
approach
larsson
et
al
larsson
et
al
emerg
trend
ht
review
literatur
discoveri
plantderiv
activ
perform
follow
pattern
emerg
weller
gupta
heinrich
et
al
plant
collect
precis
geoloc
site
collect
may
includ
whole
plant
part
leav
stem
bark
seed
root
botan
materi
dri
powder
use
mechan
mean
grounder
powder
extract
solvent
differ
temperatur
increas
polar
sequenti
extract
procedur
case
exampl
chemistri
activ
compound
unknown
first
step
import
consid
extract
method
might
influenc
chemic
composit
extract
consequ
biolog
activ
extract
dri
low
pressur
final
solid
residu
suspend
solut
compris
minim
amount
biologicalcompat
solvent
often
dmso
next
step
would
includ
test
extract
well
plate
biolog
target
program
biolog
test
often
clone
enzym
catalyt
assay
receptor
bind
assay
proteinprotein
interact
assay
even
whole
pathway
ishibashi
ohtsuki
xie
et
al
name
biolog
test
target
wholecel
also
report
cancer
cell
mazzio
et
al
kant
et
al
virusinfect
cell
yi
et
al
dai
et
al
microorgan
correia
et
al
et
al
stpierr
et
al
extract
show
activ
test
select
submit
fraction
chromatographi
fraction
typic
around
ten
test
turn
assay
activ
fraction
subject
one
sever
extra
fraction
often
use
altern
chromatograph
condit
experi
base
ht
environ
ht
methodolog
provid
us
impress
progress
term
increas
speed
assay
lower
price
inde
robot
handl
sever
thousand
test
workday
howev
initi
enthusiasm
ht
harvey
cree
sarker
nahar
appli
crude
extract
librari
target
assay
system
face
sever
issu
state
recent
thornburg
et
al
fact
ht
techniqu
realli
modifi
discoveri
process
exampl
start
extractswhich
modest
number
consid
number
plant
speci
avail
b
number
compound
ht
campaignmight
result
activ
best
case
thu
next
step
would
hydrophob
column
collect
fraction
per
chromatographi
test
exemplifi
real
bottleneck
whole
process
parallel
fraction
activ
today
partial
progress
automat
report
last
year
sharma
gupta
strategi
develop
deliv
result
detail
review
atanasov
et
al
classifi
five
group
strategi
identifi
bioactiv
compound
plant
extract
bioactivityguid
fraction
strategi
previous
mention
similar
synergydirect
fraction
strategi
metabol
profil
strategi
metabolismdirect
biotransform
focus
strategi
final
direct
phytochem
isol
strategi
group
metabol
profil
approach
detach
relationship
bioactiv
focus
compound
develop
last
year
plant
natur
product
use
highli
sensit
reproduc
analyt
method
allow
correl
chemic
profil
qualit
quantit
bioactiv
data
zampieri
et
al
parrot
et
al
wolfend
et
al
recent
progress
field
data
analysi
integr
extract
level
wolfend
et
al
final
group
direct
phytochem
isol
approach
focus
comprehens
chemic
character
plant
extract
isol
novel
scaffold
without
immedi
evalu
bioactiv
success
term
new
drug
develop
alreadi
mention
drug
natur
product
term
screen
strategi
find
activ
compound
extract
enzym
inhibitor
proteinprotein
interact
inhibitor
mani
success
also
report
exampl
screen
result
extract
approach
atanasov
et
al
mention
exhaust
imposs
liter
hundr
test
perform
eg
laboratori
bousserouel
et
al
et
al
litaudon
et
al
litaudon
et
al
columbapalomar
et
al
catteau
et
al
olivon
et
al
hundr
other
exampl
report
recent
given
tabl
inhibitori
activ
plant
extract
specif
enzym
note
panel
enzym
activ
larg
divers
exampl
tabl
reflect
current
trend
term
enzym
origin
type
work
mainli
come
cancer
diabetesobes
field
import
say
unknown
number
fail
attempt
remain
unpublish
last
thirti
year
screen
new
moleculeswheth
candid
drug
per
se
hit
compound
modifiedi
one
two
main
sourc
drug
pharmaceut
industri
screen
strategi
deliv
mix
result
sever
factor
complic
dramat
ascophyllum
nodosum
austin
et
al
analys
result
main
one
opinion
way
diseas
simplifiedor
notto
molecular
target
amen
ht
choic
molecul
screen
assay
qualiti
assay
andor
sensit
statist
consider
determin
threshold
compound
recogn
activ
final
sourc
screen
molecul
boutin
et
al
other
schmid
et
al
dufresn
thierick
mayr
bojan
bodl
et
al
expos
screen
strategi
sever
occas
consid
divers
potenti
problem
hard
identifi
univers
approach
fact
ht
promis
techniqu
deliv
mani
drug
expect
regard
price
ambit
solutionsorgan
involv
newman
cragg
sever
limit
classic
strategi
identifi
bioactiv
natur
product
first
type
limit
would
relat
collect
live
organ
access
plant
speci
exampl
probabl
still
exist
plant
collect
given
locat
would
next
time
around
especi
whole
plant
bioactiv
associ
speci
discov
process
could
hard
find
plant
popul
case
two
choic
possibl
look
speci
anoth
locat
look
locat
close
relat
speci
help
botanist
neither
solut
entir
satisfactori
chang
harvest
locat
impli
chang
secondari
metabolit
product
biosynthesi
gener
depend
control
biotic
abiot
factor
furthermor
speci
genu
might
well
express
differ
gene
code
protein
act
slightli
differ
biosynthet
pathway
lead
differ
compound
compound
synthet
differ
proport
see
discuss
divers
moreov
collect
speci
properli
report
follow
correct
taxonomi
harvest
might
even
difficult
reproduc
therebi
tabl
correspond
name
mention
review
use
articl
origin
accept
plant
speci
name
provid
supplementari
data
tabl
anoth
type
limit
relat
fact
group
perform
bioguid
discoveri
new
activ
often
confront
similar
problem
activ
extract
fraction
maintain
level
activ
b
whole
long
difficult
isol
process
lead
molecul
mundan
known
decad
c
final
product
quantiti
remain
activ
fraction
small
hope
structur
elucid
go
back
locat
origin
plant
popul
found
anymor
plant
found
extract
treatment
led
appar
lack
activ
fraction
target
event
discuss
public
obvious
therefor
bioguid
approach
exist
small
variat
mostli
technic
pave
difficulti
often
discourag
least
industri
big
program
discuss
mani
instanc
particularli
well
summar
atanasov
et
al
one
key
start
point
choic
pharmacolog
assay
use
screen
fact
target
diseas
obvious
complex
molecular
target
simplifi
univers
recogn
altern
approach
remain
elus
still
difficult
set
exampl
diseas
could
also
simplifi
phenotyp
chang
cell
origin
diseas
organ
use
stem
cell
differenti
approach
bedut
et
al
treat
model
np
extract
potenti
hundr
compoundsrevers
pharmacolog
allow
recogn
actual
target
np
compound
lyse
cell
extract
chromatograph
retain
target
protein
raut
et
al
nevertheless
cellular
phenotyp
chang
extrem
complex
understand
approach
extrem
frustrat
despit
success
outsid
np
recognit
area
nosjean
et
al
grave
et
al
actual
anoth
limit
approach
link
work
complex
mixtur
np
discoveri
sometim
sever
compound
could
contribut
synergist
global
action
diseas
like
exampl
compound
least
three
deriv
leav
salvia
miltiorrhiza
red
sage
report
act
mani
differ
level
liver
fibrosi
et
al
kind
observ
would
strongli
argu
strategi
describ
aim
discoveri
main
pure
druglik
compound
plant
extract
summari
approach
phenotyp
screen
revers
pharmacolog
would
requir
diseas
model
far
current
avail
system
domain
drug
product
fact
around
ton
per
year
salicyl
acid
produc
synthet
worldwid
http
figur
translat
billion
pill
say
order
benefit
patient
critic
amount
potenti
drug
need
consid
access
identifi
np
well
avail
critic
exampl
start
stori
compound
isol
taxu
brevifolia
bark
ten
kilogram
bark
necessari
obtain
g
pure
compound
need
treatment
one
patient
clinic
studi
tree
cut
obtain
kg
necessari
studi
lead
approv
compound
fact
antineoplast
produc
hemisynthesi
precursor
iii
isol
leav
taxu
baccata
word
altern
found
initi
procedur
take
heavi
toll
tree
initi
speci
anoth
interest
figur
deal
time
herbal
annual
demand
ginseng
root
around
ton
mathur
et
al
kind
figur
embodi
major
limit
new
drug
origin
np
sometim
disregard
research
laboratori
real
challeng
use
np
reach
tonnag
compat
drug
market
anoth
reason
np
base
project
might
challeng
consider
industri
small
amount
natur
compound
gener
accumul
plant
tissu
inde
structur
character
well
biolog
test
made
difficult
nevertheless
mani
progress
done
area
relat
structur
character
exampl
consid
grow
sensit
analyt
method
instrument
long
barrier
microgram
determin
structur
compound
would
reach
analyt
techniqu
structur
elucid
unknown
compound
base
mixtur
spectroscopi
infrar
uv
raman
mass
spectrometri
nuclear
magnet
reson
proton
c
nmr
nice
exampl
task
describ
variou
public
baker
et
al
elelimat
et
al
difficulti
also
discuss
amagata
advanc
nmr
techniqu
review
breton
reynold
harvey
et
al
gome
et
al
sever
exampl
compound
structur
solv
mass
pure
compound
lower
report
fact
situat
could
differ
one
plant
anoth
one
organtissu
anoth
even
singl
plant
speci
therefor
even
identifi
mani
compound
sampl
abl
establish
structur
would
straightforward
consid
feasibl
systemat
compendium
plant
chemic
compon
care
understand
metabol
pathway
tissu
plant
speci
product
isol
also
necessari
especi
case
hemisynthesi
use
perform
np
industri
product
instead
use
vital
organ
plant
compound
fair
concentr
one
tri
find
precursor
product
renew
part
plant
like
leav
hemisynthesi
km
brevifolia
field
yunan
provinc
china
consist
main
sourc
precursor
http
wwwyewcarecomindexphp
cite
malik
et
al
certainli
use
renew
sourc
natur
product
desir
often
enough
sustain
profit
solut
found
proven
avail
drug
pharmacopeia
natur
origin
cragg
et
al
newman
et
al
newman
cragg
da
silva
meijer
newman
cragg
newman
cragg
mani
exampl
drug
natur
origin
exist
one
found
still
common
use
plant
sapogenin
alkaloid
sterol
product
steroid
human
drug
sex
hormon
corticosteroid
contracept
drug
etc
exampl
involv
hemisynthes
modifi
np
given
quinin
least
ton
per
year
camptothecin
asano
et
al
cocain
camphor
vitamin
etc
interestingli
end
spectrum
extrem
simpl
molecul
also
np
origin
like
salicyl
acid
pain
j
b
jin
et
al
metformin
diabet
bailey
see
product
reach
industri
scale
total
synthes
use
standard
organ
chemistri
need
easi
access
chemic
divers
compound
test
mani
compound
possibl
chemic
divers
structur
import
order
better
chanc
discov
new
drug
firn
jone
inde
affin
drug
target
result
shape
electrostat
potenti
complementar
drug
bind
site
bauer
mackey
well
bind
kinet
relat
properti
desolv
conform
chang
upon
bind
ligand
flexibl
therefor
play
import
role
identifi
partial
fit
chemic
start
point
optim
medicin
chemistri
screen
compound
need
divers
shape
electrostat
match
bind
site
list
pocketom
kufareva
et
al
well
divers
structur
allow
thorough
optim
noteworthi
probabl
identifi
hit
consider
decreas
increas
complex
ligand
hann
et
al
complex
molecul
increas
size
atom
connect
result
complex
greater
number
molecul
one
screen
statist
analys
perform
natur
product
studi
chemic
divers
firn
jone
hong
molecular
properti
feher
schmidt
quinn
et
al
scaffold
divers
lee
schneider
grabowski
et
al
yongy
et
al
coverag
chemic
space
et
al
comparison
np
compound
collect
henkel
et
al
lee
schneider
grabowski
schneider
et
al
also
perform
show
np
differ
drug
synthet
compound
sever
aspect
np
consid
complex
due
number
asymmetr
center
number
carbon
ratio
ring
number
ring
junction
inde
np
display
gener
chiral
center
drug
although
number
chiral
center
number
carbon
atom
ratio
may
lower
gu
et
al
skinnid
et
al
although
clear
evid
complex
necessari
biolog
activ
firn
jone
greatli
impact
specif
clemon
et
al
np
also
display
great
divers
scaffold
lee
schneider
grabowski
et
al
yongy
et
al
instanc
greenpharma
databas
et
al
galli
et
al
contain
murcko
framework
bemi
murcko
natur
product
wherea
nci
chembl
databas
contain
littl
less
npderiv
scaffold
respect
interest
represent
diverg
divers
bioactiv
np
synthet
compound
seen
figur
graph
report
et
al
show
small
sampl
compound
natur
compound
versu
medicin
chemistryissu
compound
differ
repartit
two
popul
princip
compon
analysi
np
also
consid
biolog
divers
compound
hit
vast
divers
biolog
target
hong
singl
known
target
mean
target
highli
promiscu
compound
howev
biolog
activ
report
np
gu
et
al
extend
studi
use
dock
experi
np
target
show
mean
target
per
natur
product
comparison
drug
interact
averag
target
drug
might
exhibit
activ
five
target
mestr
et
al
jalenca
mestr
hu
et
al
reason
strong
need
easi
organ
access
chemic
divers
structur
form
librari
compound
necessari
keep
good
balanc
divers
defin
mean
compound
pairwis
dissimilar
structur
redund
ensur
greater
divers
hit
overal
hit
rate
rang
within
activ
chemic
seri
addit
compound
librari
requir
constantli
enrich
compound
fill
gap
molecular
space
interestingli
harvey
et
al
state
divers
within
biolog
relev
chemic
space
import
librari
size
biolog
relev
chemic
space
defin
proteinbind
site
potenti
ligand
anoth
point
emphas
author
commerci
avail
chemic
space
wider
explor
natur
product
universeth
first
one
evalu
compound
second
repres
compound
banerje
et
al
np
intrins
divers
major
compon
comparison
np
complex
chemic
point
view
lead
greater
shape
divers
howev
np
might
best
compound
screen
ht
campaign
due
complex
best
drugdiscoveri
perspect
inde
probabl
activ
random
target
lower
chemic
tractabl
far
optim
although
np
decent
occupi
biolog
relev
chemic
space
meet
criteria
consid
drug
like
compound
harvey
et
al
complex
might
bottleneck
optim
phase
lead
compound
thu
acquir
mani
divers
compound
possibl
necessari
drug
discoveri
program
explor
natur
exist
chemic
divers
would
must
nevertheless
design
librari
also
design
assay
understand
pathway
respons
target
patholog
need
relev
well
understood
summari
main
idea
compound
chemic
divers
possibl
necessari
feed
drug
discoveri
program
great
deal
effort
still
invest
explor
natur
chemic
divers
particular
context
natur
chemistri
advanc
organ
chemistri
introduct
background
np
area
drug
discoveri
aim
discuss
show
extent
natur
chemic
divers
natur
chemic
divers
well
strategi
potenti
embrac
divers
differ
strategi
benefit
divers
base
extens
survey
recent
public
preliminari
survey
main
origin
recent
report
natur
compound
structur
literatur
perform
take
complet
volum
journal
consid
gold
standard
np
j
natur
product
vol
three
differ
tabl
mention
speci
origin
type
compound
newli
report
sever
journal
select
special
area
like
exampl
journal
natur
product
planta
medica
tetrahedron
letter
natur
product
commun
built
upon
sampl
final
differ
strategi
benefit
divers
offer
strateg
technic
propos
base
interpret
trend
field
support
recent
ad
hoc
literatur
chemic
divers
np
known
extrem
wide
divid
sever
type
repres
challeng
chemist
biologist
divers
measur
quantifi
mani
method
use
decad
qualifi
product
librari
divers
langer
et
al
first
survey
show
main
origin
molecul
report
natur
compound
classifi
come
anim
fungi
lichen
microorgan
marin
organ
broadest
sens
term
plant
paper
deal
partial
total
synthes
natur
compound
other
describ
variou
methodolog
analys
put
asid
shown
plant
still
main
sourc
new
natur
compound
sampl
recent
ad
hoc
literatur
three
differ
tabl
construct
gather
origin
new
compound
report
sever
journal
select
special
area
although
plant
main
focu
thought
might
use
also
consid
sourc
divers
live
kingdom
also
consist
interest
sourc
explor
somehow
relat
plant
especi
case
compound
function
plant
relat
defens
bednarek
osbourn
ecolog
interact
compound
optim
evolut
accord
gunatilaka
review
natur
product
plantassoci
microorgan
gunatilaka
among
paper
review
hand
describ
compound
isol
venom
toxin
origin
marin
organ
anim
insect
snake
alik
paper
describ
compound
come
microorgan
seen
tabl
microorgan
bacteria
yeast
tradit
import
sourc
antibiot
still
sourc
new
peptid
xue
et
al
compound
peptid
also
found
close
secondari
metabolit
natur
synthes
cell
new
peptid
often
describ
journal
special
peptid
chemistri
pharmacolog
even
sourc
live
organ
tabl
give
exampl
compound
isol
lichen
fungi
spong
chemic
divers
compound
interest
today
grow
lichen
spong
much
report
might
turn
difficult
larger
scale
hand
secondari
metabolit
synthet
microorgan
grow
extrem
condit
might
also
difficult
obtain
larg
quantiti
would
therefor
interest
dig
deeper
area
done
elsewher
purpos
biotechnolog
mokash
et
al
industri
sarmiento
et
al
pharmaceut
irwin
karker
et
al
patel
oliveira
et
al
ecolog
casillo
et
al
orellana
et
al
final
tabl
give
mani
exampl
compound
isol
differ
plant
speci
differ
tissu
speci
plant
one
major
sourc
new
compound
follow
section
deal
divers
mention
compound
report
plant
tabl
survey
origin
differ
plant
speci
tree
ornament
plant
harvest
divers
area
australia
antarctica
fact
total
differ
genera
repres
differ
botan
famili
six
angiospem
two
fern
two
liverwort
moss
spikemoss
around
thu
flower
plant
group
figur
furthermor
interest
observ
remain
famili
new
compound
report
repres
small
part
total
botan
famili
defin
last
updat
angiosperm
phylogeni
group
angiosperm
phylogeni
group
et
al
illustr
new
compound
survey
isol
superasterid
superrosid
major
clade
eudicot
inde
small
survey
illustr
larg
proport
plant
speci
still
remain
underexplor
angiosperm
taxa
plant
kingdom
furthermor
import
consid
new
speci
plant
discov
quit
often
exampl
new
plant
speci
record
includ
least
one
tree
speci
mancuso
far
plant
speci
alreadi
describ
among
author
estim
investig
pharmacolog
phytochem
atanasov
et
al
clearli
indic
even
compound
remain
found
plant
also
interest
observ
review
et
al
teach
us
plant
differ
taxa
also
synthes
ident
although
rather
complex
compound
gene
duplic
neofunction
lead
extens
exist
metabol
pathway
part
mechan
identifi
plant
respons
diversif
secondari
metabolit
togeth
influenc
ecolog
factor
exampl
suggest
small
group
precursor
plant
would
synthet
full
rang
highli
divers
compound
rapidli
chang
screen
biolog
activ
afterward
mechan
adapt
would
help
plant
cope
better
biotic
abiot
pressur
moor
et
al
ecolog
understand
plant
secondari
metabolit
diversif
also
contribut
anticip
thermoactinoamid
teta
et
al
trichoderma
sp
neomacrophorin
x
kusakab
et
al
plant
speci
describ
divers
found
endproduct
pathway
along
possibl
valuabl
new
compound
recent
interest
studi
henz
ryen
backlund
discuss
chemic
angiosperm
divers
among
natur
product
evolutionari
mechan
lead
diversif
chemic
structur
function
group
secondari
metabolit
flavonoid
tropan
alkaloid
sesquiterpen
lacton
betalain
use
chemgpsnp
develop
previous
group
et
al
tool
local
compound
chemic
properti
space
measur
way
chemic
divers
word
preserv
ecolog
nich
plant
biodivers
also
serv
interest
term
chemic
divers
possibl
applic
interestingli
higher
trophic
level
also
contribut
biodivers
schuman
et
al
creat
turn
biotic
pressur
plant
may
adapt
synthet
compound
plant
multicellular
organ
organ
special
differ
function
seem
logic
think
biosynthet
pathway
could
turn
depend
part
plant
studi
certain
level
divers
exist
within
plant
tissu
main
part
plant
classic
separ
root
twig
stem
leav
flower
fruit
seed
cours
constraint
collect
make
part
suitabl
other
survey
tabl
detail
one
report
plant
speci
plant
part
isol
figur
summar
proport
new
compound
report
differ
plant
part
survey
comparison
figur
show
similarli
organspart
origin
activ
compound
report
plant
describ
ross
work
ross
ross
seem
case
studi
done
leav
hand
clear
systemat
basi
found
organ
found
welleven
small
quantitiesin
leav
nevertheless
leav
access
part
plant
renew
allow
preserv
whole
plant
obvious
also
valid
fruit
flower
avail
may
subject
season
inde
often
enough
compound
describ
part
given
plant
seem
interest
emphas
necessarili
mean
main
compon
major
aconitum
apetalum
apetaldin
allanblackia
floribunda
xanthon
mountess
et
al
alnu
viridi
hydroxyalphitol
acid
deriv
novakov
et
al
althaea
officinali
x
sendker
et
al
amorphispironon
ross
ross
author
describ
way
plant
use
tradit
medicin
differ
part
given
genu
use
alon
mixtur
prepar
rang
infus
macer
decoct
juic
dri
powder
even
fresh
organ
fruit
leav
ingest
astonishingli
recip
collect
scatter
geograph
place
last
observ
suggest
tradit
medicin
around
world
independ
found
similar
remedi
similar
diseas
sometim
use
relat
plant
speci
anoth
interest
sourc
intraspecif
chemic
divers
environ
plant
cell
biosynthes
chemic
compound
interest
well
known
compound
produc
plant
speci
vari
natur
quantiti
depend
environ
local
time
year
part
plant
extract
moor
et
al
point
particular
plant
ontogeni
also
genet
environment
variat
major
sourc
divers
plant
secondari
metabolit
exist
chemotyp
anoth
exampl
intraspecif
chemodivers
well
describ
exampl
plant
produc
essenti
oil
factor
like
moistur
salin
temperatur
nutrit
level
known
influenc
essenti
oil
product
sangwan
et
al
genotyp
could
also
significantli
influenc
chemotyp
shown
recent
valeriana
jatamansi
jone
biosynthesi
natur
product
also
differ
function
differ
individu
popul
case
exampl
compound
relat
antimicrobi
activ
summar
bednarek
osbourn
perspect
articl
chemic
divers
link
plant
defens
compound
synthet
constitut
part
normal
plant
developmentand
store
special
tissuesor
synthet
respons
pathogen
challeng
activ
transcript
specif
gene
correspond
biosynthet
pathway
base
number
gene
estim
plant
kingdom
contain
differ
metabolit
epicatechinoceanoth
acid
kang
et
al
compound
name
bold
charact
exemplifi
figur
compound
green
extract
stem
seed
red
root
blue
flower
wood
black
leav
hole
aerial
part
rhizom
fruit
bark
paper
describ
mani
differ
compound
plant
part
line
overlaid
gray
exemplifi
similar
genus
express
differ
compound
valu
singl
speci
rang
trethewey
ferni
valu
significantli
greater
microorgan
anim
oksmancaldentey
saito
global
absolut
valu
chemic
divers
compound
interest
divers
dynam
inde
wonder
wealth
chemic
structur
sourc
inspir
medicin
chemist
structur
care
identifi
relat
pharmacolog
activ
screen
also
becom
sourc
complex
phytochemist
work
structur
structureact
relat
classic
within
chemic
divers
plant
secondari
metabolit
nomenclatur
use
pharmacologist
attempt
classifi
sever
famili
natur
compound
polyketid
phenylpropanoid
terpenoid
steroid
alkaloid
base
biogenesi
pathway
origin
acet
shikim
mevalon
methylerythritol
phosphat
pathway
combin
structur
even
within
defin
group
divers
impress
exampl
terpenoid
famili
suspect
contain
least
differ
molecul
kirbi
keasl
least
flavonoid
describ
henz
ryen
backlund
certainli
differ
molecul
could
comment
discuss
appar
minor
differ
exampl
methyl
hydroxyl
moieti
might
dramat
chang
molecul
pharmacolog
properti
data
gather
tabl
previous
comment
observ
even
plant
speci
organ
differ
compound
character
like
jozilebomin
dioncophyllin
ancistrocladu
ileboensi
leav
j
li
et
al
j
li
et
al
xanthohumol
aacid
deriv
humulon
humulu
lupulu
flower
nevertheless
compound
might
slightli
differ
term
skeleton
illustr
follow
exampl
compound
structur
shown
figur
recent
isol
six
differ
speci
euphorbia
diterpenoid
slightli
differ
structur
entabietan
deriv
structur
c
gaditanon
structur
aa
floresgiubi
et
al
ingenan
deriv
structur
ab
premyrsinan
tiglian
deriv
structur
ac
dideoxyphorbol
ester
structur
ad
sooneuphoramin
structur
ae
gao
aisa
jatrophan
analog
structur
af
et
al
abietan
deriv
structur
ag
compound
origin
biosynthet
pathway
cycliz
reaction
precursor
geranylgeranyl
diphosph
sever
rearrang
allow
mani
structur
variant
diterpenoid
produc
interest
notic
despit
homolog
term
basic
scaffold
phorbol
ring
system
rearrang
compound
extrem
differ
chemic
point
view
tabl
last
statement
requir
underlin
differ
two
chemic
dramat
concern
biolog
activ
minim
concern
chemistri
exampl
chemic
differ
testosteron
estron
satur
cycl
cholesterol
backbon
minor
chemic
differ
lead
massiv
differ
pharmacolog
potenti
sourc
never
end
debat
among
screener
pharmaceut
industri
popul
chemic
librari
minor
variat
basic
skeleton
includ
primari
screen
know
miss
methyl
could
lead
nonact
viceversa
view
seem
import
gather
mani
compound
possibl
insid
chemic
seri
even
divers
seem
futil
set
minimum
result
poor
signific
level
depend
molecular
target
hit
could
found
even
minor
differ
structur
lead
new
lead
sens
work
phytochem
divers
shown
figur
becom
meaning
furthermor
compound
would
difficult
obtain
convent
organ
chemistri
method
presenc
sever
intramolecular
bridg
also
stereochemistri
final
product
see
exampl
discuss
isoprenoid
bouvier
et
al
secondari
metabolit
result
multienzymat
pathway
enzym
strict
stereospecif
multipl
possibl
term
spatial
arrang
compound
contribut
wide
rang
pharmacophor
lie
natur
product
seem
interest
mention
plant
chemic
divers
also
show
interest
divers
structur
figur
alreadi
present
differ
chemic
skeleton
np
report
tabl
compound
appear
bold
case
divers
present
figur
notic
compound
issu
microorgan
oftenbut
alwayspeptidederiv
structur
often
macrocycl
compound
newman
cragg
famili
antibiot
found
penicillium
like
thu
main
purpos
howev
fact
structur
present
figur
even
almost
randomli
chosen
differ
provid
current
state
art
medicin
chemistri
realli
surpris
consid
core
ring
scaffold
shown
natur
product
found
librari
synthet
compound
harvey
et
al
remind
part
interest
discov
structur
biolog
activ
resid
capac
use
medicin
chemistri
translat
complex
structur
simpler
molecul
amen
industri
product
time
structur
might
bear
activ
toward
protein
inhibit
reach
yet
current
access
chemic
synthon
report
discuss
accord
two
point
view
natur
compoundderiv
fragment
rodrigu
et
al
b
list
compound
issu
natur
skeleton
newman
cragg
call
np
deriv
new
drug
found
among
classic
exampl
vincristin
vinblastin
part
vincaalkaloid
zhou
rahmani
statin
sirtori
glifozin
burson
moran
ingenol
mebut
alchin
remind
current
process
move
simpl
hitsfrom
whatev
originto
complex
molecul
mean
medicin
chemistri
decor
ross
ross
synthon
process
lead
hop
defin
krueger
et
al
chakka
et
al
theoret
permit
mimic
one
complex
structur
anoth
simpler
one
bodi
techniqu
theori
put
togeth
work
order
gain
new
power
compound
new
npbase
approach
bachmann
fact
survey
data
indic
two
import
featur
np
basi
select
divers
even
includ
common
featur
like
instanc
particular
cycloheptan
structur
found
main
compound
euphorbiase
figur
high
number
asymmetr
carbon
render
synthesi
standard
organ
chemistri
difficult
imposs
instanc
exampl
number
given
tabl
consid
number
theoret
possibl
isom
n
n
number
asymmetr
carbon
case
total
number
possibl
isom
sever
thousand
rang
see
number
tabl
nevertheless
seri
impress
chemic
paper
report
complet
synthes
compound
standard
synthet
organ
chemistri
even
upscal
tour
de
forc
remain
address
kuttruff
et
al
previous
mention
deep
interest
lie
search
explor
immens
plant
chemic
divers
drug
discoveri
purpos
strategi
need
reevalu
inde
natur
secondari
metabolit
mention
herein
notso
far
fareasili
synthes
still
harvest
use
plant
discoveri
develop
purpos
industri
scale
product
compound
superior
pharmacolog
activ
isol
plant
part
must
isol
plant
extract
lay
minor
amount
certainli
previous
discuss
main
bottleneck
mani
applic
timeconsum
superior
activ
vanish
process
sever
reason
compound
alreadi
known
activ
rediscov
end
process
view
limit
overcom
develop
altern
strategi
among
strategi
seem
follow
one
could
help
solv
difficulti
link
np
discoveri
program
first
one
focus
gain
aa
z
ab
ac
ad
ae
af
ag
figur
variat
around
diterpenoid
found
six
speci
euphorbia
compound
drawn
work
euphorbia
z
entabietanetyp
diterpenoid
tiglan
aa
gaditanon
floresgiubi
et
al
ab
ingenanetyp
diterpenoid
euphorkan
ac
jatrophanetyp
ester
ad
dideoxyphorbol
ester
ae
diterpenoid
alkaloid
sooneuphoramin
gao
aisa
af
jatrophanetyp
diterpenoid
et
al
ag
abietanelactoneand
norrosanebas
heterodimer
terpenoid
note
stereospecif
compound
given
mani
differ
compound
describ
refer
tabl
entri
bold
charact
chlorin
phenanthroindolizidin
alkhdhairawi
et
al
b
triterpenoid
c
asteriscunolid
c
boumaraf
et
al
streblosid
e
glycybridin
f
neocaryachin
g
plectranthroyleanon
nzogong
et
al
h
uncarilin
geng
et
al
acid
deriv
novakov
et
al
follow
chemic
name
given
structur
fairli
simpl
complex
skeletton
ap
aq
ar
au
av
common
name
given
correspond
global
structur
core
molecul
simplifi
structur
order
give
gener
idea
variou
natur
structur
met
natur
compound
mani
variat
exist
famili
compound
ah
heptalen
zarev
et
al
ai
aj
naphthalen
ak
taxadien
al
f
azulen
kopsin
schwikkard
et
al
ao
ap
amorphispiron
muharini
et
al
aq
cephalotan
ar
xylorumphiin
waratchareeyakul
et
al
campo
et
al
isobenzo
au
aromatican
av
clerodan
bisio
et
al
aw
spiro
c
g
isobenzofuran
ax
catechinbound
ceanothanetyp
triterpenoid
kang
et
al
systemat
access
compound
plant
part
deal
use
scalabl
cultur
plant
cell
remain
capabl
produc
specif
chemic
would
allow
bypass
repetit
massiv
natura
harvest
opportun
go
back
biolog
materi
chemic
explor
remain
compound
limit
would
overcom
second
strategi
aim
appreci
known
plant
chemic
divers
inventori
np
sourc
third
strategi
focus
industri
scale
product
synthet
biolog
branch
biotechnolog
one
construct
insid
microorgan
enzymat
pathway
lead
given
compound
zhao
et
al
last
bodi
techniqu
lead
possibl
grow
thousand
liter
microorgan
thu
obtain
larg
amount
desir
product
research
discoveri
vitro
cultur
regard
plant
cell
cultur
sever
recent
review
bring
new
light
vitro
cultur
investig
purpos
well
use
valuabl
platform
highvalu
metabolit
product
wilson
robert
moscatiello
et
al
ochoavillarr
et
al
eibl
et
al
exampl
scatter
literatur
vitro
cultur
produc
compound
interest
either
use
dedifferenti
cell
callu
undifferenti
cell
meristemat
cambial
cell
calli
system
plant
suspens
cell
cultur
gener
like
exampl
acteosid
product
scrophularia
stiata
khanpourardestani
et
al
rosmarin
acid
satureja
khuzistanica
sahraroo
et
al
carotenoid
taget
erecta
et
al
hand
tissu
cultur
ie
hairi
root
also
develop
alreadi
differenti
cell
type
cultur
gener
develop
particular
purpos
often
restrict
given
compound
given
plant
camptothecin
product
ophiorrhiza
speci
asano
et
al
schisandra
chinensi
lignan
product
szopa
et
al
szopa
et
al
boeravinon
abronia
nana
sever
exampl
cultur
commerci
scale
also
describ
valid
feasibl
scalabl
labscal
largescal
paclitaxel
form
taxu
spp
cultur
rosmarin
acid
coleu
blumei
cultur
scopolamin
duboisia
spp
cultur
wilson
robert
name
nevertheless
literatur
provid
us
welldescrib
exampl
task
remain
seen
techniqu
univers
word
describ
possibl
obtain
larg
scale
plant
cell
cultur
necessarili
applic
next
cell
cultur
differ
plant
fortiori
differ
organ
plant
speci
consid
promis
approach
remain
case
challeng
experiment
process
developedor
publishedwith
gener
usag
purpos
thu
perfectli
describ
process
obtain
stemderiv
callu
leafderiv
callu
produc
anticanc
phenol
compound
fagonia
indica
khan
et
al
partial
similar
process
obtain
callu
fruit
pulp
varieti
appl
produc
high
triterpen
acid
verardo
et
al
process
obtain
callu
origin
seed
abronia
nana
kim
et
al
desert
plant
found
north
america
produc
massiv
amount
boeravinon
even
callu
scrophularia
striata
product
acteosid
khanpourardestani
et
al
seen
mani
exampl
found
literatur
remain
question
much
methodolog
vari
one
exampl
next
order
obtain
callu
obtain
cell
suspens
produc
desir
compound
gener
procedur
establish
dedifferenti
plant
cell
suspens
cultur
exist
mustafa
et
al
eibl
et
al
mani
specif
adapt
function
speci
organ
origin
cultur
condit
probabl
author
concentr
mainli
product
yield
target
compound
larger
pictur
applic
gener
view
access
test
chemic
divers
plant
one
consid
natur
divers
lie
plant
speci
environ
sourc
new
chemic
would
wonder
reli
methodolog
univers
enough
collect
biolog
materi
time
ration
cultur
cell
origin
specif
plant
organ
leav
stem
root
etc
interest
cell
cultur
cell
would
abl
biosynthes
larg
varieti
compound
quantiti
larg
enough
isol
identifi
compound
pharmacolog
activ
complet
character
stage
cultur
size
custom
expand
sever
liter
sever
ten
liter
cell
cultur
hundr
initi
result
promis
biomass
need
go
test
final
even
modif
cultur
condit
could
work
enhanc
chemic
divers
jozwiak
et
al
least
variat
within
proport
differ
secondari
metabolit
jozwiak
et
al
akbari
et
al
saad
et
al
origin
approach
thu
resid
use
plant
tissu
cell
cultur
product
scale
limit
exist
attempt
facilit
access
plant
chemic
divers
perspect
repositori
associ
plant
cell
cultur
would
valuabl
tool
versatil
term
scale
vitro
cultur
would
also
allow
bridg
gap
drug
discoveri
first
stage
develop
classic
approach
use
drug
discoverydetail
themar
quit
specif
tri
find
compound
plant
organ
specif
activ
particular
enzym
receptor
pathway
contrari
systemat
inventori
np
exist
live
organ
plant
part
exampl
would
great
interest
drug
discoveri
aspect
well
develop
aspect
discoveri
aspect
would
allow
better
use
known
natur
chemic
divers
drug
develop
aspect
would
allow
chang
sourc
np
keep
mind
import
suppli
compound
natur
origin
compani
tabl
consist
sampl
recent
report
work
natur
compound
systemat
alreadi
use
group
catalogu
chemic
compound
given
organ
given
plant
batista
et
al
sendker
et
al
et
al
sharma
et
al
fungu
chang
et
al
microorgan
mcmullin
et
al
verasteguiomana
et
al
case
idea
possibl
divers
sourc
given
compendium
plant
composit
done
ia
ross
ross
ross
inventori
organ
global
databas
would
greatli
facilit
access
divers
secondari
metabolit
plant
exampl
would
somewhat
eas
strategi
base
chemotaxonomi
describ
better
filiationsrelationship
biosynthet
pathway
differ
genu
facilit
access
type
chemic
skeleton
renew
natur
produc
sourc
leav
fruit
furthermor
tabl
indic
view
way
literatur
compil
avail
sourc
build
databas
base
publish
articl
describ
one
sever
compound
plant
part
line
remark
paper
et
al
review
avail
literatur
compound
dibenzylbutyrolacton
lignan
famili
describ
compound
chemic
famili
origin
term
plant
speci
plant
part
mani
reason
systemat
inventori
plant
chemic
compon
relat
tissu
speci
extract
would
great
use
could
difficult
complet
even
modern
fast
analyt
tool
inde
complet
compendium
real
challeng
experi
alreadi
exist
np
databas
exemplifi
challeng
exampl
napralert
experi
http
napralertorg
gather
data
scientif
paper
inform
comprehens
coverag
claim
global
data
cover
due
budgetari
constraint
organ
compound
activ
author
search
fact
last
decad
seen
develop
sever
databas
provid
systemat
collect
inform
focus
natur
compound
offer
possibl
search
structur
sourc
mechan
action
search
compound
exampl
derepnp
databas
compil
structur
data
zani
carrol
interest
review
xie
et
al
allow
comparison
fourteen
databas
focus
np
balanc
advantag
disadvantag
among
updat
version
databas
supernatur
ii
public
resourc
http
bioinformaticscharit
desupernatur
natur
compound
offer
structur
conform
banerje
et
al
seem
outperform
mani
other
harvey
et
al
xie
et
al
anoth
sourc
natur
compound
also
greenpharma
collect
wwwgreenpharmacomproduct
compoundlibrairi
gpndb
et
al
galli
et
al
use
plant
cell
organ
cultur
product
industri
scale
compound
superior
ad
valu
report
variou
review
wilson
robert
imseng
et
al
eibl
et
al
review
cite
larg
rang
applic
pharmaceut
area
suspens
cell
pacif
yew
stir
bioreactor
deliv
year
paclitaxel
cosmet
food
industri
like
cell
cultur
malu
domestica
grown
l
product
bioreactor
still
acknowledg
limit
exist
mainli
fact
timeconsum
process
involv
possibl
low
titer
possibl
somaclon
variat
appear
select
top
produc
cell
line
sever
solut
tri
avoid
kind
limit
assess
trosset
carbonel
opinion
gener
strategi
consid
altern
larg
industri
product
scale
depend
kind
applic
specif
np
pharmacolog
interest
like
podophyllotoxin
artemisinin
plumbagin
exampl
whole
set
biotechnolog
approach
develop
describ
product
larger
scale
valuabl
compound
et
al
kayani
et
al
roy
bharadvaja
strategi
quit
specif
driven
one
identifi
compound
specif
biosynthet
pathway
previous
mention
one
major
requir
approach
understand
pathway
particular
compound
biosynthes
thank
activ
seri
enzym
involv
particular
plant
part
within
last
approach
focu
plant
capac
synthet
uniqu
scaffold
endproduct
inde
use
recent
integr
approach
base
omic
analys
metabolom
proteom
transcriptom
genom
great
valu
inde
know
precursor
intermedi
biochem
statu
tissu
identifi
key
enzym
limit
step
pathway
monitor
indirectli
function
gene
involv
pathway
regul
contribut
deciph
biosynthet
rout
planta
cheallaigh
et
al
scossa
et
al
rel
eas
one
obtain
largescal
data
facilit
analys
level
whole
metabol
network
paddon
keasl
ikram
simonsen
exampl
larg
amount
transcriptom
data
easier
access
state
owen
et
al
make
possibl
identif
multistep
pathway
coexpress
analys
untarget
metabolom
furthermor
discoveri
gene
link
biosynthet
pathway
organ
cluster
open
new
opportun
adapt
methodolog
develop
initi
microorgan
plant
like
systemat
cluster
mine
algorithm
owen
et
al
scossa
et
al
review
recent
progress
made
understand
plant
biosynthet
pathway
integr
metabolom
nextgener
sequenc
base
variou
famili
compound
exampl
benzoisoquinolin
monoterpenoid
indol
alkaloid
cannabinoid
ginsenosid
withanolid
also
emphas
new
insight
area
bring
field
synthesi
np
mention
exampl
intrigu
case
caffein
biosynthesi
evolv
independ
sever
order
eudicot
least
three
metabol
pathway
evolv
separ
coopt
gene
differ
gene
famili
illustr
biosynthet
pathway
evolv
land
plant
diversif
scossa
et
al
identifi
gene
involv
reconstitut
biosynthet
pathway
interest
realiz
thank
novel
dna
construct
technolog
realiz
foreign
host
enabl
increas
product
yield
choic
host
organ
key
goal
develop
effici
platform
heterolog
gene
express
microbi
host
gener
consid
amen
plant
ferment
process
atanasov
et
al
among
classic
work
hors
like
e
coli
cerevisia
newcom
like
bacillu
subtili
pseudomona
putidaar
nikel
et
al
loeschck
thi
choi
lee
cite
anoth
interest
exampl
recent
highcelldens
ferment
strategi
develop
heterolog
product
pichia
pastori
wc
basic
strategi
consist
clone
gene
enzym
pathway
identifi
construct
larg
plasmid
famili
plasmid
encod
enzym
transfect
plasmid
microorgan
grown
afterward
purifi
product
sever
recent
review
detail
technic
advanc
synthet
biolog
multiplex
genom
engin
allow
optim
design
synthesi
pathway
involv
np
product
awan
et
al
breitl
takano
carbonel
et
al
smanski
et
al
mose
et
al
mani
exampl
found
curcumin
synthesi
reconstitut
e
coli
kang
et
al
polyunsatur
fatti
acid
product
fungu
ashbya
gossypii
ledesmaamaro
et
al
aamyrin
lupulon
ou
ginsenosid
synthesi
cerevisia
dai
et
al
yu
et
al
guo
et
al
diversif
carotenoid
biosynthet
pathway
umeno
et
al
probabl
best
exampl
econom
feasibl
process
report
product
artemisin
industri
scale
paddon
keasl
ikram
simonsen
altern
develop
plant
transform
transfect
technolog
offer
rapid
scalabl
biosynthesi
allow
consid
use
plantbas
express
platform
like
nicotiana
arabidopsi
spp
fuent
et
al
lu
et
al
reed
et
al
appelhagen
et
al
inde
consid
genet
flexibl
nativ
plant
sourc
offer
case
sever
advantag
even
microbi
host
lack
endogen
biosynthet
precursor
np
intracellular
compart
endoplasm
reticulum
relat
implement
enzym
like
cytochrom
appelhagen
et
al
advanc
plant
synthet
biolog
increas
access
np
new
synthet
rout
reed
et
al
also
allow
synthesi
newtonatur
molecul
expand
natur
plant
chemic
divers
way
analyz
total
synthes
recent
produc
literatur
use
simpl
criteria
order
evalu
feasibl
approach
case
similar
compound
find
way
clinic
evalu
set
recent
public
deal
total
synthesi
np
accord
simpl
criteria
number
cycl
compound
number
carbon
heteroatomsinclud
sulfurin
cycl
number
asymmetr
carbon
structur
tabl
nonexhaust
set
public
decid
consid
peptid
peptidederiv
macrocycl
dozen
structur
next
observ
surpris
high
number
bacteriaderiv
compound
featur
notic
previou
survey
tabl
anoth
paramet
allow
judg
feasibl
scalabl
process
yield
number
step
sens
work
exquisit
delic
enterpris
success
public
term
tour
de
forc
obviou
also
allow
emphas
necess
obtain
gener
synthet
rout
use
provid
analog
desir
np
public
compound
devoid
asymmetr
carbon
render
synthesi
easier
still
challeng
requir
sever
step
overal
poor
yield
end
spectrum
compound
consider
number
asymmetr
carbon
dimericbiscognienyn
asymmetr
carbon
namenamicin
nicola
et
al
andor
high
number
cycl
even
alway
fuse
inde
seri
three
furanbas
cycl
samala
et
al
separ
alkyl
carbon
chain
would
consider
difficulti
synthes
depend
decor
cycl
introduc
notion
asymmetri
thu
difficulti
perform
data
compar
one
gather
tabl
show
particular
case
access
chemistri
possibl
optic
isom
would
simpli
imposs
observ
cast
shadow
possibl
use
synthet
rout
industri
scale
hand
master
step
particularli
stereocontrol
one
key
case
altern
hemisynthes
solut
adopt
abund
intermediari
natur
compound
final
anoth
point
certainli
grow
number
synthet
rout
explor
assess
valid
access
common
featur
natur
compound
review
literatur
found
li
l
et
al
even
partial
essenc
show
consider
number
rout
set
permit
access
main
fuse
cycl
suillusin
suillu
granulatu
mushroom
conosilan
yuan
et
al
conocyb
siliginea
mushroom
mitrephora
glabra
tree
chamuvarinin
samala
et
al
uvaria
chama
plant
aspidofractinin
saya
et
al
aspidosperma
cylindrocarpon
tree
leucomidin
found
compound
come
differ
natur
sourc
anoth
review
summar
way
spiroacet
access
anoth
common
featur
mani
natur
compound
last
point
strongli
emphas
common
natur
throughout
live
world
basic
enzymat
system
aim
produc
secondari
metabolit
fundament
brick
mevalon
isoprenoid
nevertheless
also
clear
survey
chemistri
present
time
solut
problem
scalabl
np
product
industri
level
even
compound
extrem
activ
given
diseas
even
larg
panel
exampl
complet
synthes
np
present
kuttruff
et
al
point
earlier
present
assay
research
level
even
level
exemplif
chemic
analog
given
activ
approach
necessari
import
inde
deciph
variou
rout
compound
might
help
design
simplifi
overal
structur
case
standard
organ
chemistrybas
medicin
chemistri
decad
interplay
search
new
drug
np
strong
point
fear
destruct
nativ
forest
lead
reduct
plant
divers
would
jeopard
find
new
cure
old
new
diseas
present
essay
aim
offer
global
overview
extent
known
chemic
divers
access
use
sever
approach
chemic
divers
also
discuss
maxim
view
possibl
find
use
compound
human
unmet
medic
need
illustr
plant
natur
chemic
divers
inde
immens
knowledg
gather
plant
tip
iceberg
exemplifi
ia
ross
book
ross
ross
gather
chemic
compon
found
plant
mani
differ
compon
knowledg
certainli
scatter
world
unifi
work
done
simpl
format
could
like
one
present
tabl
complet
follow
exampl
et
al
martin
et
al
larrea
tridentata
plant
b
murraya
exotica
plant
lanceolacton
acharyya
nanda
illicium
lanceolatum
plant
bussealin
e
twigg
et
al
bussea
sakalava
plant
polyflavanostilben
b
polygonum
cuspidatum
plant
unnam
alkaloid
davison
et
al
isati
indigotica
plant
borra
et
al
narcissu
sp
plant
psiguadi
b
chapman
et
al
psidium
guajava
plant
parvineostemonin
gerling
et
al
stemona
parviflora
plant
arboridinin
kopsia
arborea
plant
adunctin
b
deth
dherang
piper
adunctum
plant
deguelin
tephrosia
vogelii
plant
englerin
hatakeyama
phyllanthu
engleri
plant
houttuynoid
jian
et
al
houttuynia
cordata
plant
mucosin
nolso
et
al
reniera
mucosa
spong
rac
renieramycin
kimura
saito
reniera
sp
kind
tool
would
incred
eas
access
plant
natur
chemic
divers
ideal
comprehens
organ
includ
data
worldwid
plant
speci
past
recent
studi
global
databas
could
furthermor
integr
one
like
genom
phylogen
speci
occurr
biosynthet
pathway
biolog
activ
chemic
classif
allen
et
al
allow
research
mine
resourc
correl
inform
henc
empow
kind
research
studi
trend
emphas
sever
author
recent
review
atanasov
et
al
harvey
et
al
state
drug
discoveri
plant
requir
multidisciplinari
approach
experi
past
tell
us
import
drug
discoveri
purpos
access
wide
divers
lie
plant
kingdom
especi
may
shrink
due
rapid
alter
biospher
order
fulli
access
whole
chemic
divers
without
jeopard
plant
biodivers
altern
way
collect
store
plant
tissu
explor
exampl
use
vitro
cultur
techniqu
allow
renew
sustain
access
plant
chemic
divers
final
purpos
give
access
workabl
quantiti
therapeut
compound
suggest
advanc
synthet
biolog
coupl
genom
bioinformat
pave
way
possibl
futur
strategi
product
compound
origin
divers
chemic
divers
scaffold
plant
natur
compound
wide
still
space
differ
strategi
largescal
product
organ
total
synthesi
simpler
scaffold
like
ephedrin
metformin
abl
synthet
step
say
reason
cost
end
spectrum
heterolog
plant
product
compound
complex
scaffold
like
taxan
multistep
biosynthesi
even
hybrid
multihost
semisynthet
strategi
imagin
develop
el
jb
wrote
review
help
pd
model
chemistri
would
like
thank
ms
luana
gessica
carmo
da
silva
help
prepar
figur
dr
natalia
sayuri
muto
help
languag
edit
manuscript
center
agrofood
pharmaceut
cosmet
valor
amazonian
bioactiv
compound
cvacba
prof
rogez
also
acknowledg
supplementari
materi
articl
found
onlin
http
supplementarymateri
